Esperion Therapeutics
ESPREsperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Esperion Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 9/20/2023 | Sell | Warren, Eric | Chief Commercial Officer | $1.2 | $924 |
| 8/18/2023 | Sell | Warren, Eric | Chief Commercial Officer | $1.4 | $344 |
| 7/19/2023 | Sell | Warren, Eric | Chief Commercial Officer | $1.6 | $168 |
| 6/21/2023 | Sell | Warren, Eric | Chief Commercial Officer | $1.5 | $894 |
| 5/17/2023 | Sell | Warren, Eric | Chief Commercial Officer | $1.6 | $356 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)